ArticleHuman vaccines & immunotherapeutics2018

Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy.

Francesco Saverio Mennini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.